… In order to help physicians make decisions for treatment of infections caused by MDR and …
options for the treatment of infections due to extended-spectrum-β-lactamase (ESBL)-, AmpC-, …

… agents in the treatment of nonsevere ESBL-producing infections from urinary sources. …
infections, it is the opinion of the authors that the use of cephamycins for severe ESBL infections …

… Extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) are a frequent …
infections worldwide. Carbapenems are nowadays the most used drugs to treat these infections…

… ß-lactams with novel non-ß-lactam ß-lactamase inhibitors (… for difficult-to-treat
carbapenemase-producing Enterobacterales (… in patients with CPE-infections treated with the …

… avoided for empiric treatment of suspected ESBL infections and should only be considered
for definitive treatment if the MIC ≤1 µg/mL. However, the site and severity of infection, local …

… infection as well as an indirect effect through their ability to produce the enzyme beta-lactamase…
part of the normal flora at the infection site and is often employed it the treatment of other …

… drugs of choice for the treatment of severe infections due to ESBL-… Agents that may be useful
for the treatment of ESBL-… for empirical treatment of serious infections associated with UTIs …

… third-generation cephalosporins are used to treat infections with ESBL-producing organisms,
… Third-generation cephalosporins should not be used to treat serious infections with ESBL-…

… invitro studies of the various P-lactamase inhibitors, the real question remainingis whether
… labile P-lactam antibiotics used to treat infections. Efficacy of P-lactamase inhibitors in vivo is …

… Given that carbapenems are necessary for treating serious infections, amikacin, cefepime, …
of infection, severity of infection, and treatment information in each episode of infection were …